发明名称 |
New azaphenylalanine derivatives are thrombine inhibitors useful to treat or inhibit thrombin, fibrin or thrombus formation in the blood |
摘要 |
<p>Azaphenylalanine derivatives (I) and their salts are new. Azaphenylalanine derivatives of formula (I) and their salts are new. [Image] R1>, Z : H, -C(=NR4>)NH2 or CH2-NH3+>Cl->; R4>H, 1-3C alkyl, OH, O-(1-3C alkyl) or NH2; R2>heterocyclic derivative of formula (1-3), azepine o r N(R8>)R9>; R5>-R7>H, 1-3C alkyl or COOR1>0>; R1>0>H or 1-3C alkyl; R8>, R9>H, 1-3C alkyl or 3-6C cycloalkyl; R1>1>H, 1-3C alkyl or benzyl; X : CH, O or S; Y : NR1>2>, O or S; R1>2>H, COCH3 or 1-3C alkyl; and R3>group of formula (4-6) or napthylsufonyl, benzylderivative of formula (9) (where R1> = -CH2-NH3+>Cl->). Provided that: (1) one of R1> and Z is H; and (2) R3>can only be napthylsulfonyl when R1> is -CH2>-NH3+>Cl-> An independent claim is also included for preparation of (I). ACTIVITY : Anticoagulant. MECHANISM OF ACTION : Thrombine inhibitor; Factor Xa inhibitor. (I) were tested for their thrombin inhibitory activity using enzyme assay. The negative logarithm of inhibitory constant for (4-{[1-{[Cyclopentyl(methyl)amino]carbonyl}-2-(2-naphthylsulfonyl)hydrazino]methyl}phenyl)methanaminium chloride was 0.031.</p> |
申请公布号 |
CH696724(A5) |
申请公布日期 |
2007.10.31 |
申请号 |
CH20030001209 |
申请日期 |
2003.01.27 |
申请人 |
LEK PHARMACEUTICAL AND CHEMICAL CO. D.D.;UNIVERSITY OF LJUBLJANA FACULTY OF PHARMACY |
发明人 |
URLEB, UROS;TRAMPUS, BAKIJA, ALENKA;OBREZA, ALES;STEGNER, MOJCA |
分类号 |
C07D223/02;A61K31/10;A61K31/15;A61K31/175;A61K31/445;A61K31/5375;A61K31/55;A61P7/02;C07C275/66;C07C311/16;C07C311/49;C07C317/14;C07D207/48;C07D211/06;C07D211/08;C07D211/60;C07D223/04;C07D275/02;C07D277/06;C07D295/16;C07D295/215;C07D403/12 |
主分类号 |
C07D223/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|